Cream for treating dark spots on the face
Part of Skin clinical trials.
This study tests a cosmetic cream to reduce dark spots on the face, including melasma and sun spots. It aims to see if the product improves the appearance of hyperpigmentation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 30 and 60 years old.
- You have dark spots on your face, such as melasma, sun spots, or spots after inflammation.
- You are available for in-person visits and phone or video check-ins.
- You are not pregnant, breastfeeding, or planning to become pregnant.
- You have not used certain medications (anti-inflammatories, immunosuppressants, antihistamines) in the last 3 weeks.
- You have not had any facial treatments (like peels or laser) in the last 4 weeks or intense sun exposure in the last 15 days.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a skincare formula for treating three types of dark spots on the face: melasma, acne marks, and age spots. It aims to see if the product is effective and gentle after 3 months of daily use.
This study tests a new cream for facial dark spots caused by sun damage, melasma, or acne. It aims to see if the cream is safe and effective over three months.
This study tests a new cream against a standard prescription cream (4% hydroquinone) to treat dark spots or melasma on the face. You will use a cream daily and avoid other skin treatments for about 4 months.
This trial tests if adding MelaB3 serum to a 35% glycolic acid peel works better than the peel alone for treating dark spots caused by melasma, acne scars, or sun damage. It may be a good option if you have mild to moderate dark spots and are willing to avoid sun exposure and other skin-lightening products.
This trial tests a microneedling technique combined with three topical medications (metformin, tranexamic acid, and a modified Kligman's formula) to treat melasma, a common skin condition causing dark patches. The goal is to see if this approach safely and effectively reduces melasma in eligible women.
This trial compares a new cosmetic serum to a standard treatment (4% hydroquinone) for facial melasma over 84 days. It may help if you have mild to moderate melasma and are looking for a gentler alternative.
Hear when a new Hyperpigmentation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.